An open-label, multi-center, long-term extension study of Zanubrutinib (BGB-3111) in patients with B-cell malignancies

  • Kenealy, Melita (Primary Chief Investigator (PCI))
  • Baker, Emma (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date13/02/2031/12/25

Keywords

  • Malignant Haematology
  • B-cell Malignancies
  • Clinical trial